These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 8135789

  • 1. Little or no expression of the cholecystokinin-A receptor gene in the pancreas of diabetic rats (Otsuka Long-Evans Tokushima Fatty = OLETF rats).
    Funakoshi A, Miyasaka K, Jimi A, Kawanai T, Takata Y, Kono A.
    Biochem Biophys Res Commun; 1994 Mar 15; 199(2):482-8. PubMed ID: 8135789
    [Abstract] [Full Text] [Related]

  • 2. Pancreatic regeneration after ethionine-induced acute pancreatitis in rats lacking pancreatic CCK-A receptor gene expression.
    Sato T, Niikawa J, Usui I, Imamura T, Yoshida H, Tanaka S, Mitamura K.
    J Gastroenterol; 2003 Mar 15; 38(7):672-80. PubMed ID: 12898360
    [Abstract] [Full Text] [Related]

  • 3. An animal model of congenital defect of gene expression of cholecystokinin (CCK)-A receptor.
    Funakoshi A, Miyasaka K, Shinozaki H, Masuda M, Kawanami T, Takata Y, Kono A.
    Biochem Biophys Res Commun; 1995 May 25; 210(3):787-96. PubMed ID: 7539259
    [Abstract] [Full Text] [Related]

  • 4. Defects of cholecystokinin (CCK)-A receptor gene expression and CCK-A receptor-mediated biological functions in Otsuka Long-Evans Tokushima Fatty (OLETF) rats.
    Nakamura H, Kihara Y, Tashiro M, Kanagawa K, Shirohara H, Yamamoto M, Yoshikawa H, Fukumitsu K, Hirohata Y, Otsuki M.
    J Gastroenterol; 1998 Oct 25; 33(5):702-9. PubMed ID: 9773935
    [Abstract] [Full Text] [Related]

  • 5. Effect of timely insulin administration on pancreatic B-cells of Otsuka-Long-Evans-Tokushima-Fatty (OLETF) strain rats. An animal model of non-insulin dependent diabetes mellitus (NIDDM).
    Ishida K, Mizuno A, Sano T, Noma Y, Shima K.
    Horm Metab Res; 1995 Sep 25; 27(9):398-402. PubMed ID: 8557237
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Defect in pancreatic exocrine and endocrine response to CCK in genetically diabetic OLETF rats.
    Tachibana I, Akiyama T, Kanagawa K, Shiohara H, Furumi K, Watanabe N, Otsuki M.
    Am J Physiol; 1996 Apr 25; 270(4 Pt 1):G730-7. PubMed ID: 8928805
    [Abstract] [Full Text] [Related]

  • 9. Cholecystokinin receptor characterization and cholecystokinin-A receptor messenger RNA expression in transgenic mouse pancreatic carcinomas and dysplastic pancreas.
    Povoski SP, Zhou W, Longnecker DS, Bell RH.
    Oncol Res; 1994 Apr 25; 6(9):411-7. PubMed ID: 7703527
    [Abstract] [Full Text] [Related]

  • 10. Adrenocortical insufficiency in Otsuka Long-Evans Tokushima Fatty rats, a type 2 diabetes mellitus model.
    Noguchi S, Ohno Y, Aoki N.
    Metabolism; 2007 Oct 25; 56(10):1326-33. PubMed ID: 17884440
    [Abstract] [Full Text] [Related]

  • 11. Lack of satiety effect of cholecystokinin (CCK) in a new rat model not expressing the CCK-A receptor gene.
    Miyasaka K, Kanai S, Ohta M, Kawanami T, Kono A, Funakoshi A.
    Neurosci Lett; 1994 Oct 24; 180(2):143-6. PubMed ID: 7700567
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Characterization of cholecystokinin receptors and messenger RNA expression in rat pancreas: evidence for expression of cholecystokinin-A receptors but not cholecystokinin-B (gastrin) receptors.
    Zhou W, Povoski SP, Bell RH.
    J Surg Res; 1995 Mar 24; 58(3):281-9. PubMed ID: 7533864
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Involvement of cholecystokinin in baseline and post-prandial whole body insulin sensitivity in rats.
    Peitl B, Döbrönte R, Drimba L, Sári R, Varga A, Németh J, Pázmány T, Szilvássy Z.
    Eur J Pharmacol; 2010 Oct 10; 644(1-3):251-6. PubMed ID: 20624386
    [Abstract] [Full Text] [Related]

  • 16. Strain differences in myenteric neuron number and CCK1 receptor mRNA expression may account for differences in CCK induced c-Fos activation.
    Gulley S, Sharma SK, Mansour M, Sullivan CN, Moran TH, Sayegh AI.
    Brain Res; 2005 Oct 05; 1058(1-2):109-19. PubMed ID: 16169531
    [Abstract] [Full Text] [Related]

  • 17. Role of cholecystokinin-A (CCK-A) receptor in pancreatic regeneration after pancreatic duct occlusion: a study in rats lacking CCK-A receptor gene expression.
    Miyasaka K, Ohta M, Tateishi K, Jimi A, Funakoshi A.
    Pancreas; 1998 Mar 05; 16(2):114-23. PubMed ID: 9510132
    [Abstract] [Full Text] [Related]

  • 18. Preventive and therapeutic effects of the protease inhibitor camostat on pancreatic fibrosis and atrophy in CCK-1 receptor-deficient rats.
    Jia D, Taguchi M, Otsuki M.
    Pancreas; 2005 Jan 05; 30(1):54-61. PubMed ID: 15632700
    [Abstract] [Full Text] [Related]

  • 19. Regulation of cholecystokinin release and transcription in a rat without gene expression of cholecystokinin-A receptor.
    Miyasaka K, Masuda M, Funakoshi A.
    Digestion; 1997 Jan 05; 58(2):104-10. PubMed ID: 9144298
    [Abstract] [Full Text] [Related]

  • 20. Otsuka Long-Evans Tokushima fatty (OLETF) rat is not a suitable animal model for the study of angiopathic diabetic retinopathy.
    Matsuura T, Yamagishi S, Kodama Y, Shibata R, Ueda S, Narama I.
    Int J Tissue React; 2005 Jan 05; 27(2):59-62. PubMed ID: 16035649
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.